...
首页> 外文期刊>Iranian journal of public health. >Clinical Research Involving Minors in International and Serbian Regulations
【24h】

Clinical Research Involving Minors in International and Serbian Regulations

机译:涉及未成年人与国际和塞尔维亚法规的临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background: Participation in clinical trials can be useful for the health of a person, in who it is conducted, but it does not have to be - it can even be harmful. Therefore, primary motive to accept such risk is hufnariity and human wish to contribute to the progress of medicine; this is expressed by personal consent. The consent, however, can be an expression of personal humanity, and for this, it is not logical that someone can give consent on behalf of someone else, as it is done by a legally authorized representative on behalf of a minor. Therefore, authors raise 3 questions: What are the reasons to consider representative's consent acceptable? How should a model of regulations look like in order to provide the most complete possible protection to a minor? Is actual regulation of minors' position within international and Serbian law, analyzed here by authors for their specific solutions, acceptable? Representative's consent is acceptable only for therapeutic research, because these can bring benefits to everyone's health, including a minor in Which those are conducted - this is an acceptable (secondary) motive of participation in the research. Expression of humanity on other's behalf, typical for non-therapeutic research, is not acceptable; this makes ban of minors' participation in non-therapeutic research more appropriate regulation model. International regulations are not in accordance to results presented in the paper for allowing participation, of minors both in therapeutic and non-therapeutic research. Serbian regulation is closer to the most acceptable regulation model. Informed consent is minimum term to be fulfilled today in order to access clinical research involving human subjects. It is the fact, however, that many are not capable of giving valid consent to participation in clinical research. Largest categories of such persons are minors, i.e. children. In general, it is considered that they are not capable of taking care of themselves, or mature reasoning and decisions making regarding personal life issues - for this reason they are not capable of giving consent to participation in clinical trials. This presumption is valid until minor's legal competency that comes with his legal age, independently if a child, is capable of reasoning even earlier.
机译:摘要背景:参与临床试验可能对一个人的健康有益,但并非必须如此-甚至有害。因此,接受这种风险的主要动机是出于幸福感和人类希望为医学进步做出贡献。这是通过个人同意表示的。但是,同意书可以表达个人的人性,为此,有人可以由他人代表他人表示同意,这是不合逻辑的,因为这是由合法授权的代表他人代表的。因此,作者提出了3个问题:认为代表同意可以接受的原因是什么?为了给未成年人提供最完整的保护,规章范本应该是什么样?作者在此处分析其对未成年人在国际和塞尔维亚法律中的地位的实际规定是否可以接受?代表的同意仅对治疗研究可接受,因为它们可以为每个人的健康带来益处,包括进行这些治疗的未成年人-这是参与研究的可接受的(辅助)动机。在非治疗研究中,代表他人表达人类是不可接受的;这使得禁止未成年人参与非治疗性研究更加合适。国际法规与文件中提出的允许未成年人参与治疗和非治疗研究的结果不一致。塞尔维亚的法规更接近最可接受的法规模型。为了获得涉及人类受试者的临床研究,知情同意书是今天必须履行的最低期限。但是,事实是,许多人没有能力有效同意参与临床研究。这种人的最大类别是未成年人,即儿童。通常,人们认为他们没有能力照顾自己,也没有能力针对个人生活问题做出成熟的推理和决策,因此,他们没有能力同意参加临床试验。该推定在未成年人的法定能力与他的法定年龄相称之前一直有效,如果孩子是独立的,甚至能够提早推理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号